Susana Puig
Researcher Next ID · RN-035240
Researcher · Biochemistry, Genetics and Molecular Biology
Madrid, Spain
- Works count
- 895
- Citation count
- 34,460
- H-index
- 91
- i10-index
- 450
Research interests
Publications
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Nature Medicine · 2022 · https://doi.org/10.1038/s41591-022-01695-5
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00065-6
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(21)00126-1
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo
JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2019.5570
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial
Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.02110
Human–computer collaboration for skin cancer recognition
Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-0942-0
Comparison of the accuracy of human readers versus machine-learning algorithms for pigmented skin lesion classification: an open, web-based, international, diagnostic study
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30333-x
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
New England Journal of Medicine · 2018 · 10.1056/nejmoa1802357
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
Nature Genetics · 2015 · https://doi.org/10.1038/ng.3373
A DNA methylation fingerprint of 1628 human samples
Genome Research · 2011 · https://doi.org/10.1101/gr.119867.110
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Nature · 2011 · https://doi.org/10.1038/nature10539
Genome-wide association study identifies three new melanoma susceptibility loci
Nature Genetics · 2011 · https://doi.org/10.1038/ng.959
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
Nature Genetics · 2011 · https://doi.org/10.1038/ng.958
Genome-wide association study identifies three loci associated with melanoma risk
Nature Genetics · 2009 · https://doi.org/10.1038/ng.411
Common sequence variants on 20q11.22 confer melanoma susceptibility
Nature Genetics · 2008 · https://doi.org/10.1038/ng.163
In vivo reflectance confocal microscopy imaging of melanocytic skin lesions: Consensus terminology glossary and illustrative images
Journal of the American Academy of Dermatology · 2007 · https://doi.org/10.1016/j.jaad.2007.05.044
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study
British Journal of Dermatology · 2004 · https://doi.org/10.1111/j.1365-2133.2004.05657.x
Current projects
No projects listed.